AUTHOR GUIDELINES

Jurnal Fitofarmaka Indonesia (JFFI) is a peer-reviewed journal published by Pharmacognosy-Phytochemistry Laboratory of Faculty of Pharmacy, Universitas Muslim Indonesia, which was first published in January 2014. JFFI published tri-times a year in January-June and July-December. This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

JFFI is a scientific journal published online and in printed versions and publishes research articles or scientific papers in the field of natural medicine with e-ISSN: 2541-2329 p-ISSN: 2356-0398.

JFFI receives writing in the form of research results, scientific studies, and brief descriptions relating to natural product samples, such as pharmacology activities, chemical natural products, formulation, comparative study, in silico, phytochemical screening, microbiology test, cosmetics of natural product, isolation, standardization, level determination, and others related to natural product research.

1. General Author Guidelines

Authors must submit their manuscripts by registering first and logging in as an author through the following URL address:

http://jurnal.farmasi.umi.ac.id/index.php/fitofarmakaindo/about/submissions#onlineSubmissions

If authors have any problems with the online submission, please contact Editorial Office at the following email: editorjfi@umi.ac.id.

The following documents should accompany the manuscripts submitted online through the online submission interface (upload as Supplementary Files):

1. Signed Author Declaration Form (ADF) form originally (scan the document after signed or signed electronically) [download the ADF form here]
2. A Covering Letter outlines the basic findings of the paper and its significance.

Three types of manuscripts are acceptable for publication: Original Research Articles, Short Communication, and Review Articles (not preferable).

2. Manuscript Template

The manuscript should be prepared according to the following author guidelines in the MS Word article template format: download here 

3. Reviewing process manuscripts

All submitted manuscripts are going through a double-blind peer-review process. The decision for publication, amendment, or rejection is based upon their reports/recommendations and made solely by Editor. If reviewers consider a manuscript unsuitable for publication in this journal, a statement explaining the basis for the decision will be sent to the authors within three months after the submission date.

4. Revision of manuscripts

Manuscripts sent back to the authors after revision should be returned to the editor without delay. The revised manuscript should be uploaded to the Online Submission Interface in the "Upload Author Version" from the Review task window. The revised manuscript returned later than three months will be considered a new submission and will be reviewed again by other peer-reviewers.

Editorial Office of Jurnal Fitofarmaka Indonesia

All correspondences should be sent to the following Editorial Office:

Ahmad Najib, B.Pharm, M.Pharm (Editor in Chief)

Editorial Office of Jurnal Fitofarmaka Indonesia Pharmacognosy-phytochemistry laboratory building, Faculty of Pharmacy, Universitas Muslim Indonesia

Jl. Urip Sumohardjo km. 5, Kampus II UMI, Makassar, South Sulawesi, Indonesia 90231, Telp.: +6281524045514, Fax.: +62411425619

Email: editorjfi@umi.ac.id

An author should first register as Author Role and may be offered as Reviewer through the following address: 

http://jurnal.farmasi.umi.ac.id/index.php/fitofarmakaindo/about/submissions#onlineSubmissionsThe author should fulfill the form as detail as possible where the star marked form must be entered. After all form textbox was filled, the Author clicks on the “Register” button to proceed with the registration. Therefore, the Author is brought to an online author submission interface where the Author should click on “New Submission”. In the Start, a New Submission section, click on “Click Here”: to go to step one of the five-step submission processes”. The following are five steps in the online submission process:

After this submission, Authors who submit the manuscript will get a confirmation email about the submission automatically. Therefore, Authors are able to track their submission status at any time by logging in to the online submission interface. The submission tracking includes a status of manuscript review and editorial process.

Jurnal Fitofarmaka Indonesia (JFFI) welcomes article submissions with charge for Article Publication (APC) of IDR 1.000.000,-, but does not charge article processing. Readers can read and download any full-text articles for free of charge. For Libraries/Individual, can read and download any full-text articles for free of charge. 

All published articles will be immediately and permanently free Open Access for everyone to read and download. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows:

• Creative Commons Attribution-ShareAlike 4.0 International (CC BY SA 4.0)

Jurnal Fitofarmaka Indonesia (JFFI) is a journal published by the Pharmacognosy-Phytochemistry Laboratory of the Faculty of Pharmacy, Universitas Muslim Indonesia, which was first published in January 2014. JFFI is a scientific journal published online and a print version. Manuscripts can be the results of experimental research or literature review that is a closely related natural product. Manuscripts in the form of research have never been published before.

According to Engelmore and Morgan, manuscript content should, in general, be organized in the following order: Title; Authors Name; Authors Affiliation; Abstract; Keywords; Introduction; Materials and Methods; Results and Discussion; Conclusions; Acknowledgments; and References. Manuscript document submitted to this journal (in one MS Word or PDF file) should be arranged as follow:

1. Body text of a manuscript article (from Title to References, without tables and figures)
2. Figure Captions and Table Captions
3. Figures (one figure per page)
4. Tables (one table per page)

Please include Covering Letter in a separated document file containing your summary of scientific finding and uploaded in Supplementary Files.

b. Section Headings

Three levels of heading are allowed as follows:

• Level 1 (Heading1 format) - 10pt, Times bold, Title Case, left-justified
• Level 2 (Heading2 format) - 10pt, Times bold, left-justified
• Level 3 (Heading3 format) - 10pt, Times bold italic, left-justified

Bullet and numbering within body text are not allowed. All sentence should be typed as a descriptive paragraph.

Tables are sequentially numbered with the table title and number above the table. Tables should be centered in the column OR on the page. Tables should be followed by a line space (12pt). Elements of a table should be single-spaced. However, double spacing can be used to show groupings of data or to separate parts within the table.  Table headings should be in 10pt not bold. Tables are referred to in the text by the table number, e.g., Table 1. Do not show the vertical line in the table. There is only a horizontal line should be shown in the table, as well as table heading.

Figures are sequentially numbered commencing at 1 with the figure title and number in the below section the figure as shown in Figure 1. Detailed recommendations for figures are as follows:

• Ensure that figures are clear and legible with typed letterings.
• Black & white or colored figures are allowed.
• If a figure spans two columns, it should be placed at the top or bottom of a page.
• Hard copy illustrations should, preferably, be scanned and included in the electronic version of the submission in an appropriate format as follows: 
• BMP - Microsoft bitmap file
• WMF - Windows Metafile Format
• EPS - Encapsulated Postscript
  • If figures cannot be scanned, the original should be placed in its location within the manuscript using wax or colorless glue.
  • The following files are permissible: 
  • Microsoft Graph
  • Microsoft Draw

Figure 1 shows an included Microsoft Draw object.

f. Equations

Equations should be numbered serially within parentheses as shown in Equation (1). The equation should be prepared using MS Equation or MS Equation Editor if you using MS 2013 (not in image format). The equation number is to be placed at the extreme right side. Symbols in the equation should be typed as a paragraph descriptive, not as a bulleted list.

g. Units, Abbreviations, and symbols

Metric units are preferred and should be consistent throughout the body text. Define abbreviations and symbols for the first time as they are introduced in the text.

The manuscript should be typed using word processors (Microsoft Word or Open Office) software. The font used throughout the paper is Times New Roman. The paper size is A4 (i.e., 210 x 297 mm), one-column format with a 2.5 cm margin at the top, a 2.5 cm margin at the bottom, 2.5 cm margin on the left, and 2 cm margin on the right. Lines are one-half spaced, justified. Page numbers should be included in the text located in the footer section of each page. Use of pronouns such as I, we, etc. is to be avoided.

Manuscript submitted to this journal should follow the heading below, except for the review article: Title; Authors Name; Authors Affiliation; Abstract; Keywords; Introduction; Research Methods; Results and Discussion; Conclusions; Acknowledgments; and References. 

This is your opportunity to attract the reader’s attention. Remember that readers are the potential authors who will cite your article. Identify the main issue of the paper within the title. Begin with the subject of the paper. The title should be accurate, unambiguous, specific, and complete. Do not contain infrequently-used abbreviations.

The title of the paper should be in 14 pt bold Times New Roman and be centered. The title should have 0 pts space above and 12 pts below.

Write Author(s) names without a title and professional positions, such as Prof, Dr, Production Manager, etc. Do not abbreviate your last/family name. Always give your First and Last names. Write clear affiliation of all Authors. Affiliation includes a name of department/unit, (faculty), a name of the university, country. Please indicate Corresponding Author (include email address) by adding an asterisk (^*) in superscript behind the name.

Author names should be in 12 pt Times Roman bold with 12 pts above and 12 pts below. Author addresses are superscripted by numerals and centered over both columns of manuscripts. Author affiliations should be in 10 pt Times Roman italic. The body of the text should commence two lines (24 points) below the last address.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

An abstract should stand alone, means that no citation in the abstract. Consider it the advertisement for your article. The abstract should tell the prospective reader what you did and highlight the key findings. Avoid using technical jargon and uncommon abbreviations. You must be accurate, brief, clear and specific. Use words which reflect the precise meaning. The abstract should be precise and honest. This section is written in English (more preferable) or Indonesian (starting in 2020 must be in the English). An abstract cannot be more than 200 words with italic Times New Roman font 10pt. Decimal numbers use points (.), not a comma (,) (Like 0.05).

An abstract must contain backgrounds (if any, maximum 1-2 sentences), objectives, short method, results or findings, and conclusion.

Keywords are the labels of your manuscript and critical to correct indexing and searching. Therefore, the keywords should represent the content and highlight of your article. Use only those abbreviations that are firmly established in the field. e.g. Extract. Each word/phrase in keyword should be separated by a semicolon (;), not a comma (,).

An Introduction, Authors should state the objectives of the work at the end of the introduction section. Before the objective, Authors should provide an adequate background (maximum 1 paragraph), and very short literatures survey/review in order to record the existing solutions/method, to show which is the best of previous researches, to show the main limitation of the previous researches, to show what do you hope to achieve (to solve the limitation), and to show the scientific merit or novelties of the paper. Avoid a detailed literature survey or a summary of the results. Do not describe a literature survey/review as author by author, but should be presented as a group per method or topic reviewed which refers to some literature.

One of the examples of novelty statement or the gap analysis statement at the end of the Introduction section (after state of the art of previous research survey):

“........ (summary of background)....... A few researchers focused on ....... There have been limited studies concerned on ........ Therefore, this research intends to ................. The objectives of this research are .........”.

m. Research Method

Instrument, materials, and methods should make readers be able to reproduce the experiment. Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described. Do not repeat the details of established methods. For the chemicals, please provide details of brand and purity (example: Alcohol Absolut (Merck, 99.8%)). For the instrument/tools, please provide details of the brand (example: Spectrophotometry UV-Visible (Thermo®). Tools such as beakers, funnels, dropper, etc do not need to be written.

 n. Results and Discussion

Results should be clear and concise. The results should summarize (scientific) findings rather than providing data in great detail. Please highlight differences between your results or findings and the previous publications by other researchers. The discussion should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

In a discussion, it is the most important section of your article. Here you get the chance to sell your data. Make the discussion corresponding to the results, but do not reiterate the results. Often should begin with a brief summary of the main scientific findings (not experimental results).

The following components should be covered in discussion: How do your results relate to the original question or objectives outlined in the Introduction section (what/how)? Do you provide interpretation scientifically for each of your results or findings presented (why)? Are your results consistent with what other investigators have reported (what else)? Or are there any differences?

Conclusions should only answer the objectives of the research. Tells how your work advances the field from the present state of knowledge. Without clear Conclusions, reviewers and readers will find it difficult to judge the work, and whether or not it merits publication in the journal. Do not repeat the Abstract, or just list experimental results. Provide a clear scientific justification for your work, and indicate possible applications and extensions. You should also suggest future experiments and/or point out those that are underway.

Mention all applicable grants and other funding that supported your research. Include individuals who have assisted you in your study: Advisors, Financial supporters, or may another supporter, i.e. Proofreaders, Typists, and Suppliers, who may have given materials. Do not acknowledge one of the author's names.

Cite the main scientific publications on which your work is based. Cite only items that you have read. Do not inflate the manuscript with too many references. Avoid excessive self‐citations. Avoid excessive citations of publications from the same region. Check each reference against the original source (authors name, volume, issue, year, DOI Number). Please use Reference Manager Applications like EndNote, Mendeley, Zotero, etc. The minimum number of references should be 15 references. 

All publications cited in the text should be included as a list of references. references are written in the author's name and year (Author, year) when they appear in the text (following the Harvard style). Reference numbers are indicated in square brackets. Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Unpublished results and personal communications are not recommended in the reference list but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either “Unpublished results” or “Personal communication”. Citation of a reference as 'in press' implies that the item has been accepted for publication.

As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, a reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.

This journal has to follow standard templates available in key reference management packages EndNote (https://www.endnote.com/support/enstyles.asp), Mendeley (https://www.mendeley.com), or Reference Manager (https://refman.com/support/rmstyles.asp). Using plug-ins to word processing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style, which is described below.

• Types of references are as follows: 
  • For a Book, see (Dewick, 2009)
  • For a Journal Article, see (Hamidu, Ahmad, & Najib, 2017), (Najib, Handayani, Ahmad, Hamidu, & Anisa, 2019)
  • For a Proceedings Paper, see (Ansary, Handayani, & Najib, 2016)
  • For a Technical Report, see (National Center for Chronic Disease Prevention and Health Promotion, 2017)
  • For a Dissertation or Thesis, see (Mauldina, 2014)
  • For an Internet Reference (not preferable), see (World Health Organization, 2018)

When preparing your reference list, the following should be avoided:

• References not cited in the text.
• Excessively referencing your work.
• Insufficiently referencing the work of others.

Examples of guideline for preparing the references list is described in the last section of this author guidelines.

References

Ansary, S. N., Handayani, V., & Najib, A. (2016). Isolation of Asaron Compound from Sweet Flag Rhizome Acorus calamus L Using Chromatotron Methods. In Proc. of The Fourth Intl. Conf. On Advances in Applied Science and Environmental Technology - ASET (pp. 1–4). USA: Institute of Research Engineers and Doctors. https://doi.org/10.15224/978-1-63248-097-2-18

Dewick, P. M. (2009). Medicinal Natural Products: A Biosynthetic Approach (3rd Ed). United Kingdom: John Wiley & Sons.

Hamidu, L., Ahmad, A. R., & Najib, A. (2017). Qualitative and Quantitative Test of Total Flavonoid Buni Fruit (Antidesma bunius (L.) Spreng) with UV-Vis Spectrophotometry Method. Pharmacognosy Journal, 10(1), 60–63. https://doi.org/10.5530/pj.2018.1.12

Mauldina, M. G. (2014). Isolasi, Elusidasi, Dan Uji Penghambatan Alfa-Glukosidase Secara In Vitro Dan In Silico Oleh Kulit Batang Antidesma bunius (L.) Spreng. Universitas Indonesia.

Najib, A., Handayani, V., Ahmad, A. R., Hamidu, L., & Anisa, R. (2019). Chemoprofiling of Active n-Hexane Fraction as Alpha-Glucosidase Inhibitors from Kanunang ( Cordia myxa L .) Leaves from Enrekang South Sulawesi. Journal of Global Pharma Technology, 11(1 Suppl.), 266–270.

National Center for Chronic Disease Prevention and Health Promotion. (2017). National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. USA. Retrieved from https://www.cdc.gov

World Health Organization. (2018). Diabetes. Retrieved March 11, 2019, from https://www.who.int/news-room/fact-sheets/detail/diabetes

As a journal Author, you have rights for a large range of uses of your article, including use by your employing institute or company. These Author rights can be exercised without the need to obtain specific permission. 

Authors publishing in Jurnal Fitofarmaka Indonesia have wide rights to use their works for teaching and scholarly purposes without needing to seek permission, including: use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees; use for internal training by author's company; distribution to colleagues for their research use; use in a subsequent compilation of the author's works; inclusion in a thesis or dissertation; reuse of portions or extract’s from the article in other works (with full acknowledgement of final article); preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article); voluntary posting on open web sites operated by author or author’s institution for scholarly purposes (follow CC BY SA License).

Authors and readers can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, even commercially, but they must give appropriate credit (cite to the article or content), provide a link to the license, and indicate if changes were made. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.